Tenderwize
Retour à la recherche

Open house Arzneimittelrabattverträge Carbamazepin, ATC N03AF01

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Dec 05, 2026 · 98 days left·Open·Supplies·Framework
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Carbamazepin, ATC N03AF01

50/100

Score d'opportunité

Needs reviewLow complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

50 / 100

Complexité

20 / 100

Facteurs de risque

No estimated value or volume commitment. The open-house model means there is no guaranteed spend; actual sales depend o...

The open-house agreement automatically becomes void if a nationwide or land-specific discount contract for the same sub...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jan 2027
  • Pharmaceutical discount agreements for Carbamazepine (ATC N03AF01) with AOK Bayern
  • Non-exclusive open-house model, not a competitive procurement
Afficher le résumé complet

This is an open-house model (non-exclusive) for pharmaceutical discount agreements on Carbamazepine (ATC N03AF01) with AOK Bayern, Germany. Any interested pharmaceutical company that meets eligibility can join at any time until December 5, 2026. Contracts run from February 1, 2025 to January 31, 2027. No estimated value is provided. Submission can be in paper or electronic with qualified electronic signature. Only German language allowed.

Risques

No estimated value or volume commitment. The open-house model means there is no guaranteed spend; actual sales depend o...

The open-house agreement automatically becomes void if a nationwide or land-specific discount contract for the same sub...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Only pharmaceutical companies (pharmazeutische Unternehmen) as potential partners

Administrative

  • Signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) required
  • Submission either in paper (hand-signed, 2 copies) or electronically with qualified electronic signature

Les exigences peuvent être incomplètes.

Acheteur

Localisation

München, DEU

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge Carbamazepin, ATC N03AF01

Open house for non-exclusive discount agreements on Carbamazepine (ATC N03AF01). All eligible pharmaceutical companies can participate. No selection; all accepted.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Jan 2025 - Jan 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Dec 05, 2026

Détails de la procédure

Date de publication
15 Dec 2024
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
766649-2024

Documents (2)

Appels d'offres similaires